A new CDC campaign "Free Mind" addresses rising drug overdoses and mental health issues among youth, offering vital resources ...

Results from the Phase III NEPTUNUS-1 (NCT05350072) and NEPTUNUS-2 (NCT05349214) trials demonstrated that ianalumab ...

The journal is standing by the study, which looked into the safety of vaccines that have aluminum ingredients.

Accelerated approval was based on results from the Phase Ib Beamion-LUNG 1 trial (NCT04886804), which showed a 75% objective ...

Today, imaging often exists independently of molecular insights, trial data, treatment decisions, and longitudinal patient ...

Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...

Radella Pharmaceuticals reveals promising Phase 1b trial results for MD-18, showcasing significant weight loss and ...

Gene Mack, CEO of Gain Therapeutics, outlines the company’s strategic approach to advancing GT-02287 through potential collaborations and financing options as they await critical Parkinson’s disease ...

GLP-1 medication users must consult physicians before surgery to mitigate anesthesia risks and ensure safe pre-operative ...

In May, Pfizer CEO Dr. Albert Bourla defended previous comments HHS officials made about mRNA vaccines. 2 At the time, he called mRNA vaccines the most utilized vaccines in human history. He cited the ...

The talks are a result of the MFN order, which seeks to make US drug prices match lower prices in international markets.

Access inequity is driven by operational and bureaucratic challenges, affecting both low-income and developed nations, beyond ...